AKYA Stock Price, Chart, Stats & News

Akoya Biosciences, Inc.
Save
64.44M
Market cap
–
Current P/E
–
Forward P/E
AKYA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.36% |
Operating margin | -48.37% |
Pretax margin | -60.39% |
Net margin | -60.54% |
Effective tax rate | -0.24% |
ROA | -30.52% |
ROE | -672.48% |
D/E | -14.22x |
Interest coverage ratio | -3.57x |
AKYA valuation
P/E | – |
P/S | 1.13x |
P/B | -10.88x |
P/CF | -3.29x |
P/FCF | -3.05x |
P/OCF | -3.29x |
PEG | -0.13x |
EV multiple | -0.05x |
About
Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition.
Similar securities
Based on sector and market capitalization
Report issue











